Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 886 AL 900

A Comprehensive Analysis on Galantamine Based Hybrids for the Management of Alzheimer's Disease

Singh YP, Prasad S, Kumar H.

Chem Biol Drug Des. 2024 Oct;104(5):e70004. doi: 10.1111/cbdd.70004.

Keep neuroinflammation in mind when addressing Alzheimer's disease: A microglia perspective

Gessi S, Mirandola P, Merighi S.

J Alzheimers Dis. 2024 Nov;102(2):314-316. doi: 10.1177/13872877241290693. Epub 2024 Nov 3.

Neurocognitive effects of proanthocyanidin in Alzheimer's disease: a systematic review of preclinical evidence

Reshma A, Subramanian A, Kumarasamy V, Tamilanban T, Sekar M, Gan SH, Subramaniyan V, Wong LS, Rani NNIM, Wu YS.

Braz J Med Biol Res. 2024 Nov 4;57:e13587. doi: 10.1590/1414-431X2024e13587. eCollection 2024.

Therapeutic role of NLRP3 inflammasome inhibitors against Alzheimer's disease

Tantra T, Rahaman T A A, Nandini, Chaudhary S.

Bioorg Chem. 2024 Dec;153:107912. doi: 10.1016/j.bioorg.2024.107912. Epub 2024 Oct 23.

Prevention and Treatment of Alzheimer's Disease Via the Regulation of the Gut Microbiota With Traditional Chinese Medicine

Long J, Zhang J, Zeng X, Wang M, Wang N.

CNS Neurosci Ther. 2024 Nov;30(11):e70101. doi: 10.1111/cns.70101.

Redox regulation, protein S-nitrosylation, and synapse loss in Alzheimer's and related dementias

Oh CK, Nakamura T, Zhang X, Lipton SA.

Neuron. 2024 Dec 4;112(23):3823-3850. doi: 10.1016/j.neuron.2024.10.013. Epub 2024 Nov 7.

Recent Advances in Therapeutics for the Treatment of Alzheimer's Disease

Thawabteh AM, Ghanem AW, AbuMadi S, Thaher D, Jaghama W, Karaman D, Karaman R.

Molecules. 2024 Oct 30;29(21):5131. doi: 10.3390/molecules29215131.

Dual inhibition of butyrylcholinesterase and p38α mitogen-activated protein kinase: A new approach for the treatment of Alzheimer's disease

Ferjančič Benetik S, Knez D, Obreza A, Košak U, Gobec S.

Pharmacol Ther. 2024 Dec;264:108748. doi: 10.1016/j.pharmthera.2024.108748. Epub 2024 Nov 7.

Insights on therapeutic approaches of natural anti-Alzheimer's agents in the management of Alzheimer's disease: A future perspective

Mahajan K, Sharma S, Gautam RK, Goyal R, Mishra DK, Singla RK.

J Alzheimers Dis. 2024 Dec;102(4):897-923. doi: 10.1177/13872877241296557. Epub 2024 Nov 10.

The phospho-tau cascade, basal forebrain neurodegeneration, and dementia in Alzheimer's disease: Anti-neurodegenerative benefits of acetylcholinesterase inhibitors

Moss DE, Perez RG.

J Alzheimers Dis. 2024 Dec;102(3):617-626. doi: 10.1177/13872877241289602. Epub 2024 Nov 12.

Dietary interventions in mitigating the impact of environmental pollutants on Alzheimer's disease - A review

Khandayataray P, Murthy MK.

Neuroscience. 2024 Dec 17;563:148-166. doi: 10.1016/j.neuroscience.2024.11.020. Epub 2024 Nov 13.

Endothelial Dysfunctions in Blood-Brain Barrier Breakdown in Alzheimer's Disease: From Mechanisms to Potential Therapies

Yue Q, Leng X, Xie N, Zhang Z, Yang D, Hoi MPM.

CNS Neurosci Ther. 2024 Nov;30(11):e70079. doi: 10.1111/cns.70079.

Passive anti-amyloid β immunotherapy in Alzheimer's disease-opportunities and challenges

Heneka MT, Morgan D, Jessen F.

Lancet. 2024 Nov 30;404(10468):2198-2208. doi: 10.1016/S0140-6736(24)01883-X. Epub 2024 Nov 14.

Phase 1 Studies of the Anti-Tau Monoclonal Antibody JNJ-63733657 in Healthy Participants and Participants with Alzheimer's Disease

Galpern WR, Triana-Baltzer G, Li L, Van Kolen K, Timmers M, Haeverans K, Janssens L, Kolb H, Nandy P, Aida K, Shimizu H, Mercken M, Sun H.

J Prev Alzheimers Dis. 2024;11(6):1592-1603. doi: 10.14283/jpad.2024.163.

Roles of TREM2 in the Pathological Mechanism and the Therapeutic Strategies of Alzheimer's Disease

Lin M, Yu JX, Zhang WX, Lao FX, Huang HC.

J Prev Alzheimers Dis. 2024;11(6):1682-1695. doi: 10.14283/jpad.2024.164.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias